A novel natural-derived tilapia skin collagen mineralized with hydroxyapatite as a potential bone-grafting scaffold
Collagen is widely used in medical field because of its excellent biocompatibility and bioactivity. To date, collagen for biomedical use is always derived from bovine or swine. The purpose of this study was to evaluate collagen-based biomaterials from non-mammalian donors for bone repair. Thus, tila...
Saved in:
Published in | Journal of biomaterials applications p. 8853282221086246 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.08.2022
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Collagen is widely used in medical field because of its excellent biocompatibility and bioactivity. To date, collagen for biomedical use is always derived from bovine or swine. The purpose of this study was to evaluate collagen-based biomaterials from non-mammalian donors for bone repair. Thus, tilapia skin collagen-hydroxyapatite (T-col/HAp) scaffolds were fabricated in three different proportions and then cross-linked with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide-N-hydroxysuccinimide (EDC-NHS). The scaffolds were evaluated for their microstructure, chemical and physical properties, mechanical strength and degradability. Then the in vitro responses of bone mesenchymal stem cells (BMSCs) to the scaffolds were investigated in terms of cellular proliferation, differentiation, and mineralization. At last, the scaffolds were implanted into rat skull critical defections to investigate the potential of osteogenic activities. As a result, the pore sizes and the porosities of the scaffolds were approximately 106.67-196.67 μm and 81.5%-66.7%. Pure collagen group showed a mechanical strength of 0.065 MPa, and the mechanical strength was significantly enhanced almost 17 times and 32 times in collagen/HAp ratio 1:4 and 1:9 groups. In vitro studies revealed the most prominent and healthy growth of BMSCs in collagen/HAp ratio 1:4 group. All the scaffolds showed certain osteogenic activities and those loaded with small amount of hydroxyapatite showed the strongest bioactivities. The micro-CT showed that the critical bone defect was almost filled with generated bone 6 months after implantation in collagen/HAp ratio 1:4 group. The biomechanics tests further confirmed the highest generated bone strength was in the collagen/HAp ratio 1:4 group. This study indicated aquatic collagen might be a potential alternative for type I collagen from mammals in bone tissue engineering. The combination of collagen and inorganic materials was also important and appropriate inorganic component loading can achieve both osteogenic quality and osteogenic efficiency to a certain extent. |
---|---|
AbstractList | Collagen is widely used in medical field because of its excellent biocompatibility and bioactivity. To date, collagen for biomedical use is always derived from bovine or swine. The purpose of this study was to evaluate collagen-based biomaterials from non-mammalian donors for bone repair. Thus, tilapia skin collagen-hydroxyapatite (T-col/HAp) scaffolds were fabricated in three different proportions and then cross-linked with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide-N-hydroxysuccinimide (EDC-NHS). The scaffolds were evaluated for their microstructure, chemical and physical properties, mechanical strength and degradability. Then the in vitro responses of bone mesenchymal stem cells (BMSCs) to the scaffolds were investigated in terms of cellular proliferation, differentiation, and mineralization. At last, the scaffolds were implanted into rat skull critical defections to investigate the potential of osteogenic activities. As a result, the pore sizes and the porosities of the scaffolds were approximately 106.67-196.67 μm and 81.5%-66.7%. Pure collagen group showed a mechanical strength of 0.065 MPa, and the mechanical strength was significantly enhanced almost 17 times and 32 times in collagen/HAp ratio 1:4 and 1:9 groups. In vitro studies revealed the most prominent and healthy growth of BMSCs in collagen/HAp ratio 1:4 group. All the scaffolds showed certain osteogenic activities and those loaded with small amount of hydroxyapatite showed the strongest bioactivities. The micro-CT showed that the critical bone defect was almost filled with generated bone 6 months after implantation in collagen/HAp ratio 1:4 group. The biomechanics tests further confirmed the highest generated bone strength was in the collagen/HAp ratio 1:4 group. This study indicated aquatic collagen might be a potential alternative for type I collagen from mammals in bone tissue engineering. The combination of collagen and inorganic materials was also important and appropriate inorganic component loading can achieve both osteogenic quality and osteogenic efficiency to a certain extent. |
Author | Wang, Zhe Deng, Shu Ren, Bo Peng, Cheng Peng, Yang Hou, Shuai Yao, Shiyu Shang, Yuli Ma, Shiqing Huang, Zhaohui |
Author_xml | – sequence: 1 givenname: Shiyu orcidid: 0000-0003-3657-3671 surname: Yao fullname: Yao, Shiyu organization: 74671Tianjin Medical University Second Hospital, Tianjin, China – sequence: 2 givenname: Yuli surname: Shang fullname: Shang, Yuli organization: 74671Tianjin Medical University Second Hospital, Tianjin, China – sequence: 3 givenname: Bo surname: Ren fullname: Ren, Bo organization: Knee and Ankle Ward of Sports Medicine Center, Xi'an, China – sequence: 4 givenname: Shu surname: Deng fullname: Deng, Shu organization: 1816The Forsyth Institute, Cambridge, MA, USA – sequence: 5 givenname: Zhe surname: Wang fullname: Wang, Zhe organization: 74671Tianjin Medical University Second Hospital, Tianjin, China – sequence: 6 givenname: Yang surname: Peng fullname: Peng, Yang organization: 74671Tianjin Medical University Second Hospital, Tianjin, China – sequence: 7 givenname: Zhaohui surname: Huang fullname: Huang, Zhaohui organization: Yantai Desheng Marine Biotechnology Co, Ltd, Yantai, China – sequence: 8 givenname: Shiqing surname: Ma fullname: Ma, Shiqing organization: 74671Tianjin Medical University Second Hospital, Tianjin, China – sequence: 9 givenname: Cheng surname: Peng fullname: Peng, Cheng organization: 74671Tianjin Medical University Second Hospital, Tianjin, China – sequence: 10 givenname: Shuai surname: Hou fullname: Hou, Shuai organization: 117865Tianjin Medical University General Hospital, Tianjin, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35345923$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8tOwzAURC0Eog_4ADbIPxDwM3GWVQUFqRIbWFc38XVrcJ0odgvl64kErGYxR0czM3Ieu4iE3HB2x3lV3TNjtBRGCMGZKYUqz8iUa8kKw4SYkFlK74wxXavykkyklkrXQk5JWtDYHTHQCPkwQCgsDv6IlmYfoPdA04ePtO1CgC1GuvcRR8p_j8Snzzu6O9mh-zpBD9lnpJAo0L7LGLOHQJtxY7EdwGUftzS14FwX7BW5cBASXv_lnLw9Prwun4r1y-p5uVgXrVQsF8gBhQHNTCOkscYpAC4rIWCspXFGWa40uNrpxrU1NtqViJVx0BrF0Io5uf319odmj3bTD34Pw2nz_178AINcX4Q |
CitedBy_id | crossref_primary_10_1002_adhm_202202042 crossref_primary_10_1093_rb_rbad030 crossref_primary_10_3390_jfb14040235 crossref_primary_10_4103_denthyp_denthyp_13_24 crossref_primary_10_1007_s10853_022_07368_5 crossref_primary_10_1016_j_cobme_2023_100476 crossref_primary_10_1016_j_bioadv_2024_213780 crossref_primary_10_1021_acsbiomaterials_4c00580 crossref_primary_10_1155_2022_5271892 crossref_primary_10_1002_biot_202300251 crossref_primary_10_3390_ijms24010009 |
ContentType | Journal Article |
DBID | NPM |
DOI | 10.1177/08853282221086246 |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 1530-8022 |
ExternalDocumentID | 35345923 |
Genre | Journal Article |
GroupedDBID | --- .2N 01A 0R~ 1~K 29J 31X 31Z 4.4 53G 5GY 5VS AABOD AACTG AAJPV AAMGE AAPEO AATAA AATBZ ABAWP ABCCA ABHQH ABJIS ABJNI ABLUO ABPNF ABQKF ABQXT ACDXX ACGFS ACIWK ACJER ACLZU ACOXC ACPRK ACROE ACSIQ ACTQU ACUAV ACUIR ACXKE ADRRZ AEDFJ AENEX AEPTA AESZF AEUHG AEUIJ AEWDL AEWHI AFKRG AFMOU AFQAA AGKLV AGWFA AGWNL AIOMO AJUZI ALFTD ALMA_UNASSIGNED_HOLDINGS ANDLU ARTOV AUTPY AUVAJ AYAKG B8Z B94 BBRGL BDDNI BPACV BYIEH CS3 DH. DO- DU5 DV7 EBS EMOBN F5P FHBDP GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HF~ HZ~ J8X JCYGO K.F M4V N9A NPM O9- OVD P.B P2P PQQKQ Q1R Q83 ROL S01 SCNPE SFC SFK SFS SFT SFX SGV SGZ SPJ SPP SPV STM TEORI |
ID | FETCH-LOGICAL-c340t-e1ae28a508b238d8f4aa13722a34038f84d145af9f5bfc9eb5f6ee78fac840ed2 |
IngestDate | Wed Oct 16 00:41:48 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | hydroxyapatite Natural-derived osteogenesis scaffold tilapia skin collagen |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c340t-e1ae28a508b238d8f4aa13722a34038f84d145af9f5bfc9eb5f6ee78fac840ed2 |
ORCID | 0000-0003-3657-3671 |
PMID | 35345923 |
ParticipantIDs | pubmed_primary_35345923 |
PublicationCentury | 2000 |
PublicationDate | 2022-08-01 |
PublicationDateYYYYMMDD | 2022-08-01 |
PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of biomaterials applications |
PublicationTitleAlternate | J Biomater Appl |
PublicationYear | 2022 |
SSID | ssj0005946 |
Score | 2.3943312 |
Snippet | Collagen is widely used in medical field because of its excellent biocompatibility and bioactivity. To date, collagen for biomedical use is always derived from... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 8853282221086246 |
Title | A novel natural-derived tilapia skin collagen mineralized with hydroxyapatite as a potential bone-grafting scaffold |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35345923 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELW2RULlgPgsUEA-cIuMEsdOnOO2AlVI9EIrlVNlJ2M2YrtZsdlK7Z3_zdiJQ3aBCrhYUZxPv6fJZPxmTMgbY5IkT0zKYiglEyrLmAFrkcuQFTyGzPpE4Y8n2fGZ-HAuzyeT7yPV0ro1b8ub3-aV_A-quA9xdVmy_4DscFHcgduIL7aIMLZ_hfE0WjRXMI98dU49ZxXe9Ao9yLZ2OWo6Wn31KnNEGi8RXda-wnR9ExTns-vKiVi0E1W34Fac0dGyaZ1-CIEzzQLYl2_aemH0qtTWNvONZT1HzqzL4tdt987ReFJ8sCrax2Q_zerr9RDVCcHqz-t5Pcz8dHbwsBlcbOgj2rP1OESBf7dBIIdfmGBWY-aSekemUqGj4DSs3K31xLs45K_23M8ox7cdi5AsLz3AqUyFLLr05dt7t0psh64dspMrZyxPXMgn6IQKkfXT4b5S1_az7JG74fytXxPvopw-IPd7OOi0I8pDMoHFI3JvVHHyMVlNqacM3aIM7SlDHWVooAwdUYY6ytBNylC9opoOlKEblKGBMk_I2ft3p0fHrF93g5WpiFsGiQauNLruBh26SlmhdZLmnGvsTpVVokqE1Law0tiyACNtBpArq0slYqj4U7K7wBs-I1SYvFTOzAM3IhOV4rICWyaVkTI1uX5O9rsRu1h2xVUuwli--GPPAdn7SbKX5I5FZsMrdA1b89pD9wOSAGZ0 |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+novel+natural-derived+tilapia+skin+collagen+mineralized+with+hydroxyapatite+as+a+potential+bone-grafting+scaffold&rft.jtitle=Journal+of+biomaterials+applications&rft.au=Yao%2C+Shiyu&rft.au=Shang%2C+Yuli&rft.au=Ren%2C+Bo&rft.au=Deng%2C+Shu&rft.date=2022-08-01&rft.eissn=1530-8022&rft.spage=8853282221086246&rft_id=info:doi/10.1177%2F08853282221086246&rft_id=info%3Apmid%2F35345923&rft_id=info%3Apmid%2F35345923&rft.externalDocID=35345923 |